Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 24075621

Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported outcome results of a randomised phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2013 Nov
First author
Basch E

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Urol. 2013 Nov;10(11):619. doi: 10.1038/nrurol.2013.236.
    note
    Source null
    related pmid
    24145475
    relationship
    Comment in

Authors and identifiers

  1. name
    Basch E
    type
    Author
  2. name
    Autio K
    type
    Author
  3. name
    Ryan CJ
    type
    Author
  4. name
    Mulders P
    type
    Author
  5. name
    Shore N
    type
    Author
  6. name
    Kheoh T
    type
    Author
  7. name
    Fizazi K
    type
    Author
  8. name
    Logothetis CJ
    type
    Author
  9. name
    Rathkopf D
    type
    Author
  10. name
    Smith MR
    type
    Author
  11. name
    Mainwaring PN
    type
    Author
  12. name
    Hao Y
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Basch E
    type
    Author
  2. name
    Autio K
    type
    Author
  3. name
    Ryan CJ
    type
    Author
  4. name
    Mulders P
    type
    Author
  5. name
    Shore N
    type
    Author
  6. name
    Kheoh T
    type
    Author
  7. name
    Fizazi K
    type
    Author
  8. name
    Logothetis CJ
    type
    Author
  9. name
    Rathkopf D
    type
    Author
  10. name
    Smith MR
    type
    Author
  11. name
    Mainwaring PN
    type
    Author
  12. name
    Hao Y
    type
    Author
bibliography ids
  1. nci-bib-d6878f360d6d7c76b5eaf3ab
book metadata
content sha256
945333f6dd3aa6c5c8a94c42b821478fbd2c1361435b612ece88168701e1ebb4
document type
citation
dois
  1. 10.1016/S1470-2045(13)70424-8
electronic publication date
display
2013 Sep 25
precision
day
year
2013
evidence scope
bibliographic_metadata_only
id
pubmed:24075621
immutable id
pubmed:24075621@945333f6dd3aa6c5c8a94c42b821478fbd2c1361435b612ece88168701e1ebb4
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
12
name
The Lancet. Oncology
nlm unique id
100957246
pages
1193-9
volume
14
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Urol. 2013 Nov;10(11):619. doi: 10.1038/nrurol.2013.236.
    note
    Source null
    related pmid
    24145475
    relationship
    Comment in
outcomes validated
false
pmid
24075621
provenance
batch id
0a08f044391426feb8ef
provider
NCBI PubMed ESummary
record sha256
a2b197d728c50dbe5603e23f95ad82b150c88a8adee5412df6428835db233f81
response sha256
d94e6242343e5962374663e5e5f0191e7b595329228d2e360db95a280e588409
retrieved at
2026-09-09T23:46:57.614689+00:00
publication date
display
2013 Nov
precision
month
year
2013
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Meta-Analysis
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/24075621/
title
Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported outcome results of a randomised phase 3 trial.

Preserved source evidence · Not medical advice